Aussie-led international team develop groundbreaking new platform to fast-track lifesaving brain research
The Neurodesk platform will enable scientists to accelerate research on conditions by enabling faster processing and analysis of neuroimaging data.
In summary
- An international team led by Australian researchers has developed a groundbreaking platform that will transform neuroimaging data analysis worldwide.
- Neurodesk will enable scientists to accelerate research on conditions by enabling faster processing and analysis of neuroimaging data.
- Brain research requires the analysis of massively detailed data sets generated by increasingly powerful techniques.
An international team led by Australian researchers has developed a groundbreaking platform that will transform neuroimaging data analysis worldwide. The Neurodesk platform will enable scientists to accelerate research on conditions such as epilepsy, dementia, schizophrenia and traumatic brain injury by enabling faster processing and analysis of neuroimaging data.
Brain research requires the analysis of massively detailed data sets generated by increasingly powerful techniques to measure brain structure and function such as MRI, MEG and EEG.
Led by Swinburne University of Technology, University of Queensland, and University of Sydney, Neurodesk addresses the analysis challenges presented by these data sets through an open source platform that can be installed and operated anywhere.
“Our platform makes a continuously expanding range of cutting-edge analytic techniques and software accessible to researchers across the world,” says Swinburne project lead and Director of Neuroimaging Professor Tom Johnstone.
“It allows researchers to leverage the most powerful supercomputers and cloud platforms on an individual researcher’s laptop, and is easy to install and update.”
Creating Neurodesk required an international team with expertise across signal and image processing, medical physics, software engineering, AI and machine learning. The open source Neurodesk platform is designed to support transparent and reproducible research, so that scientists can share and cross-validate their analyses and accelerate research in critical areas.
Neurodesk is supported by the Australian Research Data Commons (ARDC), the Australian National Imaging Facility and the Australian Brain Alliance with international partners including Harvard, MIT, and University College London.
With extra funding, the team is looking to broaden its scope to other neuroimaging methods and applications that will fast track the process of diagnosis and treatment for brain related illnesses.
-
Media Enquiries
Related articles
-
- Technology
- Health
- Science
- University
- Aviation
- Engineering
Swinburne’s Mobile Innovation Lab hits the road
Swinburne’s Mobile Innovation Lab is a cutting-edge mobile facility designed for research, industry collaboration, STEM education, training and outreach.
Thursday 06 November 2025 -
- Social Affairs
New online hub supports improved employment for people with disability
Australia’s Centre for Inclusive Employment has launched a suite of online resources designed to increase employment for people with disability.
Monday 03 November 2025 -
- Health
World-first guide of psychological strategies for struggling aged care residents developed by Swinburne researchers
Swinburne has led the development of a world-first guide of psychological strategies for residents in aged care homes.
Tuesday 28 October 2025 -
- Astronomy
- Technology
- Science
- Aviation
- Engineering
Shaping space innovation at the International Astronautical Congress
The 76th International Astronautical Congress (IAC) united over 7,000 delegates from more than 90 countries to explore the future of space. Swinburne staff and students delivered 20 talks, panels and presentations, showcasing Australia’s growing leadership in research and education.
Friday 10 October 2025 -
- Health
Australia’s first research trial using psychedelics to treat depression produces promising findings
Promising findings have emerged from Australia’s first research trial using psychedelics to treat depression at Swinburne.
Tuesday 14 October 2025